Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy

Author:

Cho Hyungwoo1ORCID,Yoon Dok Hyun2,Lee Jung Bok3,Kim Sung-Yong4,Moon Joon Ho5,Do Young Rok6,Lee Jae Hoon7,Park Yong8,Lee Ho Sup9,Eom Hyeon Seok10,Shin Ho-Jin11,Min Chang-Ki12,Kim Jin Seok13ORCID,Jo Jae-Cheol14,Kang Hye Jin15,Mun Yeung-Chul16,Lee Won Sik17,Lee Je-Jung18,Suh Cheolwon2,Kim Kihyun19,

Affiliation:

1. Department of Internal Medicine; Asan Medical Center, University of Ulsan College of Medicine; Seoul South Korea

2. Department of Oncology; Asan Medical Center, University of Ulsan College of Medicine; Seoul South Korea

3. Department of Clinical Epidemiology and Biostatistics; Asan Medical Center, University of Ulsan College of Medicine; Seoul South Korea

4. Division of Hematology-Oncology, Department of Internal Medicine; Konkuk University School of Medicine, Konkuk University; Seoul South Korea

5. Department of Hematology-Oncology; Kyungpook National University Hospital; Daegu South Korea

6. Department of Hemato-Oncology; Keimyung University Dongsan Medical Center; Daegu South Korea

7. Division of Hematology/Oncology; Gachon University Gil Medical Center; Incheon South Korea

8. Division of Hematology-oncology, Department of Internal Medicine; Korea University School of Medicine; Seoul South Korea

9. Department of Internal Medicine; Kosin University College of Medicine; Busan South Korea

10. Department of Hematology-Oncology; Center for Hematologic Malignancy, National Cancer Center; Goyang-si South Korea

11. Department of Internal Medicine; Pusan National University Hospital; Busan South Korea

12. Department of Internal Medicine; Seoul St. Mary's Hospital, The Catholic University of Korea; Seoul South Korea

13. Department of Internal Medicine; Yonsei University College of Medicine, Severance Hospital; Seoul South Korea

14. Department of Hematology and Oncology; Ulsan University Hospital, University of Ulsan College of Medicine; Ulsan South Korea

15. Department of Internal Medicine; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences; Seoul South Korea

16. Department of Internal Medicine; Ewha Womans University School of Medicine; Seoul South Korea

17. Department of Internal Medicine; Inje University Busan Paik Hospital; Busan South Korea

18. Department of Hematology-Oncology; Chonnam National University Hwasun Hospital; Hwasun South Korea

19. Division of Hematology/Oncology, Department of Medicine; Sungkyunkwan University School of Medicine, Samsung Medical Center; Seoul South Korea

Publisher

Wiley

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3